| Identification | Back Directory | [Name]
C8 PEG2 CERAMIDE | [CAS]
212116-76-2 | [Synonyms]
C8 PEG2 CERAMIDE
C8 PEG(2000) Ceramide
C8 PEG(5000) Ceramide
N-OCTANOYL-SPHINGOSINE-1-[SUCCINYL(METHOXY POLYETHYLENE GLYCOL) 2000]
N-OCTANOYL-SPHINGOSINE-1-{SUCCINYL[METHOXY(POLYETHYLENE GLYCOL)750]};C8 PEG750 CERAMIDE
N-OCTANOYL-SPHINGOSINE-1-{SUCCINYL[METHOXY(POLYETHYLENE GLYCOL)2000]};C8 PEG2000 CERAMIDE
N-OCTANOYL-SPHINGOSINE-1-{SUCCINYL[METHOXY(POLYETHYLENE GLYCOL)5000]};C8 PEG5000 CERAMIDE | [Molecular Formula]
(C2H4O)nC31H57NO6 | [MDL Number]
MFCD02265684 | [MOL File]
212116-76-2.mol |
| Hazard Information | Back Directory | [Description]
C8 PEG Ceramide, MW 750 is used for liposome preparation with NMR studies and PEGylated lipoplexes preparation. | [Uses]
C8 PEG-Ceramide is a lipid product. C8 PEG-Ceramide can synthesize lipid bilayer carrier and can be used for drug delivery[1][2]. | [References]
[1] Karanth H, et, al. pH-sensitive liposomes--principle and application in cancer therapy. J Pharm Pharmacol. 2007 Apr;59(4):469-83. DOI:10.1211/jpp.59.4.0001
[2] Chen L, et, al. Co-delivery of Doxorubicin and Ceramide in a Liposomal Formulation Enhances Cytotoxicity in Murine B16BL6 Melanoma Cell Lines. AAPS PharmSciTech. 2019 Feb 4;20(3):99. DOI:10.1208/s12249-019-1316-0 |
|
|